Terms: = Kidney tumors AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA
5 results:
1. Tumor microenvironment immune subtypes for classification of novel clear cell renal cell carcinoma profiles with prognostic and therapeutic implications.
Wang Q; Hu J; Kang W; Wang J; Xiang Y; Fu M; Gao H; Huang Z
Medicine (Baltimore); 2021 Mar; 100(11):e24949. PubMed ID: 33725966
[TBL] [Abstract] [Full Text] [Related]
2. The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
Ballotti R; Cheli Y; Bertolotto C
Mol Cancer; 2020 Dec; 19(1):170. PubMed ID: 33276788
[TBL] [Abstract] [Full Text] [Related]
3. LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis.
Yang Y; Meng L; Wu S; Li Y; Zhong Y; Xu F; Zhou XC; Li GQ; Xu GL; Peng KF
Int Immunopharmacol; 2020 Dec; 89(Pt A):106999. PubMed ID: 33045563
[TBL] [Abstract] [Full Text] [Related]
4. Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients.
Wang Q; Zhang J; Tu H; Liang D; Chang DW; Ye Y; Wu X
J Immunother Cancer; 2019 Nov; 7(1):334. PubMed ID: 31783776
[TBL] [Abstract] [Full Text] [Related]
5. [Sunitinib inhibits the expressions of co-stimulatory molecule ligands on dendritic cells].
Ding C; Mai H; Chen L; Zhang B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):437-41. PubMed ID: 27053605
[TBL] [Abstract] [Full Text] [Related]
